Vaxcyte, Inc. (PCVX) Presents At Cantor Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Vaxcyte, Inc. (PCVX)
Company Research
Source: Seeking Alpha
Grant Pickering - Co-Founder, CEO & Director Andrew Guggenhime - President & CFO James Wassil - Executive VP & COO Conference Call Participants Carter Gould - Cantor Fitzgerald & Co., Research Division Presentation Carter Gould Research Analyst Okay. Good afternoon. Welcome to the Cantor Global Healthcare Conference. My name is Carter Gould, biopharmaceutical analyst here at Cantor. Thank you, everyone, for joining us. I'm pleased to welcome Vaxcyte to the stage. We are joined by CEO, Grant Pickering; Andrew Guggenhime, President and CFO; and Jim Wassil, COO. Gentlemen, thank you very much. I think before we get started, maybe just a brief overview of the company and any other opening comments from you, Grant. Grant Pickering Co-Founder, CEO & Director Yes, sure. First of all, Carter, thank you for having us. Thank you all for coming. Vaxcyte is a company focused on vaccines. We have a proprietary cell-free protein synthesis platform that allows us to perfor
Show less
Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCVX alerts
High impacting Vaxcyte, Inc. news events
Weekly update
A roundup of the hottest topics
PCVX
News
- Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Vaxcyte (NASDAQ:PCVX) was given a new $77.00 price target on by analysts at Leerink Partners.MarketBeat
- Medicxi Announces €500 Million Fund V [Yahoo! Finance]Yahoo! Finance
- Medicxi closes fifth fund to back ‘asset-centric' startups [Yahoo! Finance]Yahoo! Finance
- Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.MarketBeat
PCVX
Earnings
- 11/4/25 - Miss
PCVX
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/4/25 - Form 10-Q
- PCVX's page on the SEC website